Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Çağla ERDOĞAN"'
Publikováno v:
Türk Yoğun Bakim Derneği Dergisi, Vol 22, Iss 2, Pp 110-115 (2024)
Objective: Tocilizumab (TCZ) is a recombinant humanized anti-IL-6 receptor monoclonal antibody that is beneficial in critically ill COVID-19 patients. However, the clinical efficacy and safety of immunosuppressants (including tocilizumab, sarilumab a
Externí odkaz:
https://doaj.org/article/eea6d2d7a18448f0b75056094878d6d2
Publikováno v:
Volume: 16, Issue: 1 67-71
Pamukkale Medical Journal
Pamukkale Tıp Dergisi
Pamukkale Medical Journal
Pamukkale Tıp Dergisi
Purpose: Acute kidney injury diagnosed patients are in need of renal replacement therapy (RRT). Continuous RRT is believed to be safer because the rates of fluid and solute removal are slower than with intermittent hemodialysis. In many centers, CRRT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd956932b9757ec3af1068224357be17
https://doi.org/10.31362/patd.1198297
https://doi.org/10.31362/patd.1198297
Autor:
Çağla Erdoğan, Gaye Baycik
Publikováno v:
Volume: 12, Issue: 1 346-362
İnönü Üniversitesi Hukuk Fakültesi Dergisi
İnönü Üniversitesi Hukuk Fakültesi Dergisi
Covid-19 hastalığının sosyal sigortalar hukuku açısından iş kazası, meslek hastalığı veya hastalık olarak nitelendirilmesi, sigortalıların haklarını etkiler. Salgın bir hastalık, sigortalının kişisel hayatında bulaşabileceği
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f370f6a0890f822721e65981ae9a2908
https://doi.org/10.21492/inuhfd.891824
https://doi.org/10.21492/inuhfd.891824
Publikováno v:
Therapeutics and Clinical Risk Management
Ebru Apaydin DoÄan,1 Umuttan DoÄan,2 Emine Genç,3 ÇaÄla ErdoÄan,1 Bülent OÄuz Genç3 1Department of Neurology, School of Medicine, Akdeniz University, Antalya, Turkey; 2Department ofCardiology, School of Medicine, Akdeniz University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e47c107aeb91d6a54c6e096c77adc8f
https://www.dovepress.com/adjunctive-lacosamide-treatment-for-adult-focal-onset-epilepsy-focus-o-peer-reviewed-article-TCRM
https://www.dovepress.com/adjunctive-lacosamide-treatment-for-adult-focal-onset-epilepsy-focus-o-peer-reviewed-article-TCRM
Publikováno v:
International Journal Of Psychiatry and psychological Researches.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e32aad6c0526232bbd19b2f68607f44
https://doi.org/10.17360/uhppd.2018.2.4
https://doi.org/10.17360/uhppd.2018.2.4
Publikováno v:
Epilepsybehavior : EB. 76
Objective The objective of this study was to evaluate the efficacy, tolerability, and retention rates for zonisamide (ZNS) in older adult patients with focal-onset epilepsy. Patients and methods Chart reviews of patients aged 60 years and older with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b763074e3be0c7cb330bd5a3392e48
https://pubmed.ncbi.nlm.nih.gov/28927711
https://pubmed.ncbi.nlm.nih.gov/28927711
Publikováno v:
Epilepsybehavior : EB. 75
The differential diagnosis of generalized tonic-clonic seizures (GTCS), psychogenic nonepileptic seizures (PNES), and syncope constitutes a major challenge. Misdiagnosis rates up to 20 to 30% are reported in the literature.To assess the clinical util
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2baf19be4a57f551ddd8fb9b70670026
https://pubmed.ncbi.nlm.nih.gov/28806632
https://pubmed.ncbi.nlm.nih.gov/28806632